ArticleObesity surgery2025
Risk Factors of Iron Deficiency and Iron Deficiency Anemia After Laparoscopic Sleeve Gastrectomy: A Retrospective Cohort Study.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMetabolic and bariatric surgery (MBS) can effectively improve obesity and its related complications, but it may lead to side effects such as iron deficiency (ID) and iron deficiency anemia (IDA). However, the specific risk factors for ID and IDA after laparoscopic sleeve gastrectomy (LSG) remain unclear.
methodsWe retrospectively enrolled 465 patients who underwent LSG from April 2014 to December 2021. The risk factors for postoperative ID and IDA were evaluated using logistic regression analysis. Patients who underwent LSG from December 2020 to December 2021 were given low-dose iron and vitamin B12 orally based on the iron-containing multivitamin supplementation throughout the year after surgery. We analyzed the incidence of postoperative ID and IDA in patients who received additional prophylactic treatment compared with those who did not.
resultsOne hundred one (21.7%) patients were diagnosed with ID, 23(4.9%) patients with IDA, and 19 (4.1%) cases with anemia of chronic disease (ACD) before LSG. One year after LSG, 53 (11.4%) patients were diagnosed with ID, 50 (10.8%) patients with IDA, and 32 (6.9%) cases with ACD. Female sex (OR = 3.660, 95% CI 1.676 ~ 7.995, P = 0.001) and preoperative anemia (OR = 2.139, 95% CI 0.992 ~ 4.613, P = 0.052) were associated with an increased risk of ID and IDA independently. The higher level of iron saturation (OR = 0.914, 95% CI 0.887 ~ 0.942, P < 0.001) was identified as a protective factor against postoperative anemia. The incidence of ID and IDA was reported in 12.0% of patients taking 0.1 g of iron succinate and 0.5 mg of vitamin B12 orally once a day. For patients who did not receive prophylactic medication, the incidence 1 year after surgery was 12.6%, which showed no statistical difference (P = 0.858).
conclusionsIn conclusion, the incidence of anemia increased after LSG. Female sex and preoperative anemia are independent risk factors for ID and IDA after LSG. The higher level of iron saturation was a protective factor against postoperative anemia. Low-dose prophylactic medication does not significantly reduce the incidence of ID and IDA.
Indexed as
Identifiers
41053294What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.